Get startedLog in
    Picture of Centessa Pharmaceuticals logo

    CNTA — Centessa Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Centessa Pharmaceuticals Announces Dosing In PRESent-2 Study Evaluating SerpinPC

    Picture of Centessa Pharmaceuticals logoCentessa Pharmaceuticals
    11/07/2023 08:35
    July 11 (Reuters) - Centessa Pharmaceuticals PLC
 260y.F :
    * CENTESSA PHARMACEUTICALS ANNOUNCES DOSING OF FIRST SUBJECT
IN
REGISTRATIONAL PRESENT-2 STUDY EVALUATING SERPINPC FOR THE
TREATMENT OF HEMOPHILIA B WITHOUT INHIBITORS

Source text for Eikon:  ID:nGNEnllxh 
Further company coverage:  260y.F 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Centessa Pharmaceuticals

    See all news